Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Bristow, MD,PhD
ARCA Biopharma, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
97 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arca Clinical Research Site #612
Calgary, Alberta, Canada
- Arca Clinical Research Site #624
Vancouver, British Columbia, Canada
- Arca Clinical Research Site #611
Cambridge, Ontario, Canada
- Arca Clinical Research Site #621
Cambridge, Ontario, Canada
- Arca Clinical Research Site #601
Hamilton, Ontario, Canada
- Arca Clinical Research Site #609
London, Ontario, Canada
- Arca Clinical Research Site #623
Newmarket, Ontario, Canada
- Arca Clinical Research Site #618
Oshawa, Ontario, Canada
- Arca Clinical Research Site #613
Ottawa, Ontario, Canada
- Arca Clinical Research Site #619
Toronto, Ontario, Canada
- Arca Clinical Research Site #616
Waterloo, Ontario, Canada
- Arca Clinical Research Site #603
Montreal, Quebec, Canada
- Arca Clinical Research Site #607
Montreal, Quebec, Canada
- Arca Clinical Research Site #614
Montreal, Quebec, Canada
- Arca Clinical Research Site #625
Saint-Jérôme, Quebec, Canada
- Arca Clinical Research Site #602
Sherbrooke, Quebec, Canada
- Arca Clinical Research Site #626
Trois-Rivières, Quebec, Canada
- Arca Clinical Research Site #615
Québec, Canada
- Arca Clinical Research Site #726
Budapest, Hungary
- Arca Clinical Research Site #727
Budapest, Hungary
- Arca Clinical Research Site #728
Budapest, Hungary
- Arca Clinical Research Site #729
Budapest, Hungary
- Arca Clinical Research Site #733
Debrecen, Hungary
- Arca Clinical Research Site #732
Kaposvár, Hungary
- Arca Clinical Research Site #730
Pécs, Hungary
- Arca Clinical Research Site #731
Szeged, Hungary
- Arca Clinical Research Site #734
Szolnok, Hungary
- Arca Clinical Research Site #781
Capelle aan den IJssel, Netherlands
- Arca Clinical Research Site #779
Gorinchem, Netherlands
- Arca Clinical Research Site #776
Groningen, Netherlands
- Arca Clinical Research Site #780
Helmond, Netherlands
- Arca Clinical Research Site #782
Leiderdorp, Netherlands
- Arca Clinical Research Site #786
Roosendaal, Netherlands
- Arca Clinical Research Site #777
Sneek, Netherlands
- Arca Clinical Research Site #783
Stadskanaal, Netherlands
- Arca Clinical Research Site #784
Tiel, Netherlands
- Arca Clinical Research Site #752
Bialystok, Poland
- Arca Clinical Research Site #757
Gdansk, Poland
- Arca Clinical Research Site #753
Krakow, Poland
- Arca Clinical Research Site #751
Lodz, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2014
- Primary completion
- 28 Dec 2017
- Completion
- 28 Dec 2017
- Last update posted
- 26 Sept 2022
- Registered enrollment
- 267
- Registry id
- NCT01970501
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.